Skip to content

ScaiVision: our software platform

At the core of our company is Scailyte’s best-in-class analytical platform ScaiVision™. It unravels hidden secrets of complex single-cell multiomics data to extract composite biomarkers associated with different cell populations. Using a convolutional neural network, ScaiVision automatically learns molecular patterns associated with relevant clinical outcomes. These signatures can then be applied to classify new samples.

Talks

Targets & Cell Types in Immuno-Oncology Europe 2023

Presentation details

Title: Biomarker Discovery By Single-Cell Multi-Omics Analysis And AI

Diana Stoycheva , Principal Expert in Immunology & Single-cell Analysis at Scailyte 

Tuesday, 14th November 2023

NextGen Omics 2023

Presentation details

Title: Generating Clinically Relevant Insights Through Integrating Single-Cell Multi-Omics Data And Artificial Intelligence

Dennis Goehlsdorf, Machine Learning Engineer at Scailyte

Thursday, 9th November 2023

BioTech X 2023

Presentation details

Title: Enabling Precision Medicine by Combining Single-cell Multi-Omics Data Analysis and Artificial Intelligence

Diana Stoycheva , Principal Expert in Immunology & Single-cell Analysis at Scailyte 

Wednesday, 4th October 2023

LSX Congress USA 2023

Presentation details

Track: AI / Machine Learning / Advanced Software (Techbio), Oncology, Big Data / Blockchain / Predictive Analytics

Peter Nestorov, Founder & CEO, at Scailyte 

Wednesday, 13th September 2023

IO Summit 2023

Presentation details

Title: Enabling Precision Medicine by combining multi-omics analysis and artificial intelligence

Diana Stoycheva , Principal Expert in Immunology & Single-cell Analysis at Scailyte 

Tuesday, 21st June 2023

Future Labs Live 2023

Presentation details

Title: Integrating AI into the drug discovery workflow from biomarker treatment response to drug MOA identification

Cinzia Donato , R&D Manager Women’s Health at Scailyte 

Tuesday, 2nd June 2023

NextGen Omics Boston 2023

Presentation details

Title: Discovering next-generation biomarkers through integrating single-cell ‘omics and artificial intelligence.

Sarah Carl, Director of Data Science at Scailyte 

Tuesday, 30th March 2023

Bio-Europe Spring 2023

Presentation details

Title: Enabling precision medicine by combining multi-omics analysis and artificial intelligence

Corinne Solier, SVP Corporate & Technology Development at Scailyte 

Tuesday, 22th March 2023

Biomarkers UK 2023

Presentation details

Title: Discovering next-generation biomarkers through integrating single-cell ‘omics and artificial intelligence.

Sarah Carl, Director of Data Science at Scailyte 

Tuesday, 28th February 2023

BioTechX 2022

Discovering next-generation biomarkers through integration of single-cell biology and artificial intelligence
Single-cell technologies have enabled the generation of vast amounts of data from human tissues with unprecedented resolution. While numerous cell atlas efforts have made strides toward describing and cataloging cellular
Read More

Presentation details

Title: Discovering next-generation biomarkers through integration of single-cell biology and artificial intelligence.

Sarah Carl, Director of Data Science at Scailyte

Tuesday, 8th November 2022